Clinical Report: Cardiovascular Assessment Before Surgery in Cancer Patients
Overview
Cancer patients undergoing non-cardiac surgery face significant cardiovascular risks, necessitating careful preoperative assessment. Current strategies can improve outcomes by integrating cancer history into risk stratification and employing specific screening measures.
Background
Cancer patients represent a high-risk group for perioperative cardiovascular complications due to the prevalence of underlying cardiovascular diseases and the effects of cancer therapies. With a significant number of surgeries being time-sensitive, optimizing cardiovascular health before surgery is crucial. However, existing guidelines provide limited oncology-specific recommendations, highlighting the need for tailored approaches in this population.
Data Highlights
No numerical data available in the source material.
Key Findings
Cancer patients often exhibit multiple cardiovascular risk factors, increasing the likelihood of perioperative complications.
Incorporating cancer history into risk stratification can enhance preoperative evaluations.
Lower thresholds for transthoracic echocardiography and BNP screening are recommended for patients at risk for cancer therapy-related cardiac dysfunction.
Functional capacity assessment using METs or tools like the Duke Activity Status Index aids in decision-making.
Coronary revascularization should follow standard indications rather than routine prophylactic intervention.
Multidisciplinary collaboration is essential for optimizing surgical safety and reducing cardiovascular complications.
Clinical Implications
Clinicians should adopt a holistic approach to preoperative cardiovascular assessment in cancer patients, integrating patient-specific factors and surgical risks. Utilizing validated risk tools and biomarkers can guide decision-making and improve outcomes.
Conclusion
A structured, evidence-based approach to cardiovascular assessment in cancer patients undergoing surgery is critical for minimizing perioperative risks. Ongoing research and guideline updates will further refine these strategies.
by Carl Zehner, Noah I. Beinart, Jung Hyun Kim, Andrea Ruesta Carrion, Angelica Paniagua-Bojorges, Silvia Fernanda López Moreno, Bernardo Casso-Chapa, Keila Ostos Mendoza, Venkata Subrahmanya Kumar Samanthapudi, Jonghae Lee, Kun Yuan Chu, Oanh Hoang, Gilbert F. Mejia, Anita Deswal, Nicolas L. Palaskas, Sivareddy Kotla, Nhat-Tu Le, Efstratios Koutroumpakis, Syed Wamique Yusuf, Jun-ichi Abe, Michael S. Ewer
